Labostro, Rhine .
HRN: 25-41-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2024
CEFUROXIME 1.5GM (VIAL)
07/01/2024
07/07/2024
IV
550mg
Q8
UTI
Waiting Final Action